Delisting riskPopularity #2,803
Akebia Therapeutics (AKBA)
Markets kidney-disease medicines while advancing rare-renal and HIF programs.
$0.9750
After hours+0.00 (+0.13%)
At close$0.9737(+3.75%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 39.79% | 110.26M shares | |
|---|---|---|---|
| 177 holders · as of Jun 30, 2026 | |||
| Insiders | 1.57% | 4.34M shares | |
| 13 holders · as of Aug 10, 2026 | |||
| Other | 58.64% | 162.51M shares | |
| remainder | |||
277.11M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
177 holders · 110.26M shares · 39 new positions · 106 increased · 35 reduced · 38 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 19.99M | 7.21% | +1.29M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 11.32M | 4.09% | +155.4K | Aug 13, 2026 |
| AQR Capital Management LLC | 9.15M | 3.30% | +7.36M | Aug 14, 2026 |
| Geode Capital Management, LLC | 6.73M | 2.43% | +275.1K | Aug 12, 2026 |
| State Street Corp | 5.39M | 1.95% | −6.22M | Aug 7, 2026 |
| Jacobs Levy Equity Management, Inc | 4.27M | 1.54% | +3.84M | Aug 14, 2026 |
| Acadian Asset Management LLC | 4.00M | 1.45% | +2.63M | Aug 13, 2026 |
| Goldman Sachs Group Inc | 3.69M | 1.33% | +86.3K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.20% | 19.22M | 13G | Jan 21, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 29, 2026 | Erik Ostrowskiofficer: SVP, CFO, CBO & Treasurer | Sale | 56,019 | $1.11 | 616,616 |
| Mar 4, 2026 | John P. Butlerdirector, officer: CEO and President | Purchase | 69,270 | $1.25 | 3,367,064 |
| Feb 2, 2026 | John P. Butlerdirector, officer: CEO and President | Sale · 4 lots | 341,305 | $1.39 | 3,206,233 |
| Feb 2, 2026 | Erik Ostrowskiofficer: SVP, CFO, CBO & Treasurer | Sale | 34,951 | $1.39 | 672,635 |
| Feb 2, 2026 | Carolyn M. Rucciofficer: SVP, Chief Legal Officer | Sale · 3 lots | 69,772 | $1.39 | 588,378 |
| Feb 2, 2026 | Steven Keith Burkeofficer: SVP, Chief Medical Officer | Sale · 3 lots | 67,658 | $1.39 | 948,432 |
| Feb 2, 2026 | Nicholas Grundofficer: Chief Commercial Officer | Sale · 2 lots | 84,829 | $1.39 | 561,750 |
| Feb 2, 2026 | Richard C. Malabreofficer: SVP, Chief Accounting Officer | Sale · 2 lots | 49,524 | $1.39 | 299,390 |
House and Senate disclosures
Not reported.